Class 514/877 - GALLSTONE

Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter involving the treatment or prevention of
No. of patents: 30
Last issue date: 03/09/1999

Browse patents
Browse applications

Number	Title	Issue Date
5880101	Clinical uses of polyene macrolides The present invention relates to the use of at least one polyene macrolide for the preparation of pharmaceutical compositions for the treatment of diseases that are associated with an impaired energy turnover. Particularly, the present inventions allows t...	03/09/1999
5510114	Slow release pharmaceutical composition containing a bile acid as an active ingredient A slow-release pharmaceutical composition containing a bile acid as active ingredient and comprising at least one bioadhesive substance and at least one high specific gravity substance, an aliquot thereof being enteric coated and the remainder being non-e...	04/23/1996
5441748	Agents for distributing gallstones An aqueous agent for disintegrating gallstones containing an alkali metal carbonate such as sodium or potassium hydrogen carbonate and optionally N-acetylcysteine....	08/15/1995
5405621	Compositions of gastric acid-resistant microspheres containing buffered bile acids Disclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, preventing colon ...	04/11/1995
5262172	Compositions of gastric acid-resistant microspheres containing buffered bile acids Disclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of col...	11/16/1993
5256640	Gallstone mitigation by nutrient stimulated gallbladder contraction Nutritional supplements and methods of use of the supplements to maximally stimulate gallbladder contraction in patients undergoing rapid weight loss, to prevent the build up of bilary sludge and/or gallstones....	10/26/1993
5212202	Therapeutic cholesterol gallstone dissolution method A method and apparatus are disclosed for treating a patient having cholesterol calculi which involves infusing into the biliary tract of said patient a C5 -C6 ester having a boiling point in the range of 80°-140° C. in an amount an...	05/18/1993
5079240	Synthetic conjugated bile acid and method of use thereof A method is described for the replacement of bile acid in the biliary tract during conditions of bile acid deficiency which comprises administering an effective amount of a synthetic bile acid comprising the reaction product of a natural bile acid and an ...	01/07/1992
4902718	Calcium homeostasis compositions and methods for controlling calcium metabolism This invention concerns novel calcium normalizing compositions containing as the active agent the amino acid methionine, and/or one or more related compounds including certain metabolic precursor compounds, and novel methods employing the compositions for...	02/20/1990
4892868	Derivatives of biliary acids, process for the production thereof and corresponding pharmaceutical compositions New derivatives of chenodeoxycholic, ursodeoxycholic, cholic and ursocholic acids, bearing a methyl group in the side chain, in an alfa position to the carboxylic group, the corresponding nor- and di-nor- derivatives, and the corresponding conjugates with...	01/09/1990
4767783	Gallstone dissolver A gallstone dissolver comprises the following active ingredients (A) and (B); (A) a compound selected from the group consisting of fatty acid monoglycerides of C-6 to C-12, fatty acid diglycerides in liquid phase at 30° C., fatty acid triglycerides in li...	08/30/1988
4758596	Method for therapeutic use of methyl tertiary-butyl ether Method for dissolving cholesterol calculus in vitro or in vivo comprising contacting the cholesterol calculus with methyl tertiary-butyl ether....	07/19/1988
4746654	Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation The present invention relates to products of the formula ##STR1## where R1 is H or alkyl, n is an integer from 0 to 10, and R2 is chosen from amongst H, unsubstituted or substituted alkyl radicals, a ##STR2## a substituted ...	05/24/1988
4704281	Medicinal vegetable composition for treating some hepatic and biliary diseases The medicinal vegetable composition for treating some hepatobiliary diseases, according to the invention, contains an association of the plants Epilobium hirsutum L., Chamaenerion palustre Schreb. and Chamaenerion angustifolium (L.)Scop., their ratio bein...	11/03/1987
4464399	Octodiol, a solvent for direct dissolution of cholesterol gallstones The use of a compound having the general formula: ##STR1## wherein n is 0 or a small integer, normally from 1 to 3; R is an alkyl or alkenyl group containing from 4 to 18 carbon atoms; and X is oxygen, sulfur or amide ##STR2## with the furt...	08/07/1984
4448786	4-Naphthyl and substituted naphthyl-3-hydroxy-3-pyrroline-2,5-diones and their use as inhibitors of glycolic acid oxidase Novel 4-substituted-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate kidney stone formation. A novel process for their preparation is also disclosed....	05/15/1984
4439449	Medicament for diminution of oxalate development and excretion in urine A method for the treatment of undesired uroliths with benzoic acid is disclosed....	03/27/1984
4431660	(4'-Biphenylyloxy and-thio-oxy)-3-hydroxy-3-pyrroline-2,5-diones and a method of treating calcium oxalate renal lithiasis therewith Novel 4-substituted-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate renal lithiasis....	02/14/1984
4431652	4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives of the formula: ##STR1## where X and Y are independently selected from the group consisting of hydrogen, halogen, and C1-6 alkyl; provided that positions 2 and 6 of t...	02/14/1984
4428959	4-Alkylsubstituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase Novel 4-alkylsubstituted-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate kidney stone formation. A novel process for their preparation is also disclo...	01/31/1984
4377588	4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase Novel 4-(substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate renal lithiasis....	03/22/1983
4349561	4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase Novel 4-substituted-3-hydroxy-3-pyrroline-2,5-diones are disclosed which inhibit glycolic acid oxidase and thus are useful in the treatment and prevention of calcium oxalate kidney stone formation. A novel process for their preparation is also disclosed....	09/14/1982
4264583	Gallstone dissolution compositions and method Polyol fatty acid polyesters are safe and effective agents for dissolving radiolucent gallstones when administered orally, either alone or, preferably, in conjunction with a litholytic bile acid....	04/28/1981
4263272	Pharmaceutical composition of prolonged action containing bile acids The present invention relates to a composition for oral use containing a bile acid as active principle, particularly suitable for the lysis of calculi of cholesterol origin, characterized in that it is in such a form as to yield up its active principle ov...	04/21/1981
4241047	Novel medicinal composition for the treatment of biliary lithiasis The invention concerns a novel medicinal composition for the treatment of biliary lithiasis. The active principle of the composition is formed by the association of hymecromone (4-methyl-7-hydroxycoumarine) and chenodeoxycholic acid. The medicament is adm...	12/23/1980
4205086	Method for the treatment of gallstones A method for the treatment of gallstones is disclosed herein which comprises perfusing adjacent the gallstones a liquid form of a physiologically-compatible mixture of fatty acids and/or alcohol esters of fatty acids. The mixture preferably comprises octa...	05/27/1980
4178386	Inhibitors of glycolic acid oxidase 2-Hydroxy-3-butynoic acid is disclosed which inhibits glycolic acid oxidase and thus is useful in the treatment and prevention of calcium oxalate urolithiasis (calcium oxylate kidney and bladder stone disease)....	12/11/1979
4083972	Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue Compositions for inhibiting anomalous deposition and mobilization of calcium phosphates in animal tissue, comprising an effective amount of an alkali metal, ammonium or substituted ammonium carbonyldiphosphonate in a pharmaceutical carrier; and a method f...	04/11/1978
4057630	Antiarthritic compositions comprising bis-coordinated gold(1+) salts and methods of producing antiarthritic activity Pharmaceutical compositions having antiarthritic activity comprising phosphine or phosphite bis-coordinated gold(1+) salts and methods of producing antiarthritic activity by administering internally, preferably orally, said compositions....	11/08/1977
3988443	Azacycloalkane-2,2-diphosphonic acids Azacycloalkane-2,2-diphosphonic acids having the formula ##EQU1## wherein R is a member selected from the group consisting of hydrogen and alkyl having from 1 to 3 carbon atoms and n is an integer from 3 to 5; as well as their water-soluble salts. Th...	10/26/1976

PatentStorm

Bizarre Patents

PatentStorm News

Class 514/877 - GALLSTONE